ES2072442T3 - Composiciones farmaceuticas. - Google Patents

Composiciones farmaceuticas.

Info

Publication number
ES2072442T3
ES2072442T3 ES90911879T ES90911879T ES2072442T3 ES 2072442 T3 ES2072442 T3 ES 2072442T3 ES 90911879 T ES90911879 T ES 90911879T ES 90911879 T ES90911879 T ES 90911879T ES 2072442 T3 ES2072442 T3 ES 2072442T3
Authority
ES
Spain
Prior art keywords
pharmaceutical compositions
delivery
compositions
lysophosphatidyl
calcitonin
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Lifetime
Application number
ES90911879T
Other languages
English (en)
Inventor
Lisbeth Illum
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Kyowa Kirin Services Ltd
Original Assignee
Danbiosyst UK Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Danbiosyst UK Ltd filed Critical Danbiosyst UK Ltd
Application granted granted Critical
Publication of ES2072442T3 publication Critical patent/ES2072442T3/es
Anticipated expiration legal-status Critical
Expired - Lifetime legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/24—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing atoms other than carbon, hydrogen, oxygen, halogen, nitrogen or sulfur, e.g. cyclomethicone or phospholipids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0034—Urogenital system, e.g. vagina, uterus, cervix, penis, scrotum, urethra, bladder; Personal lubricants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0043—Nose

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Engineering & Computer Science (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Oil, Petroleum & Natural Gas (AREA)
  • Medicinal Chemistry (AREA)
  • Biophysics (AREA)
  • Epidemiology (AREA)
  • Molecular Biology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Medicinal Preparation (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)

Abstract

COMPOSICIONES PARA EL SUMINISTRO TRANSMUCOSAL, EJ. INTRANASAL, QUE INCLUYEN EN UN COMPUESTO DE LISOFOSFATIDIL-GLICEROL COMO EL REFORZADOR DE LA ABSORCION. LOS COMPUESTOS PREFERENTES PARA EL SUMINISTRO SON LA INSULINA Y LA CALCITONINA.
ES90911879T 1989-08-18 1990-08-16 Composiciones farmaceuticas. Expired - Lifetime ES2072442T3 (es)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
GB898918879A GB8918879D0 (en) 1989-08-18 1989-08-18 Pharmaceutical compositions

Publications (1)

Publication Number Publication Date
ES2072442T3 true ES2072442T3 (es) 1995-07-16

Family

ID=10661831

Family Applications (1)

Application Number Title Priority Date Filing Date
ES90911879T Expired - Lifetime ES2072442T3 (es) 1989-08-18 1990-08-16 Composiciones farmaceuticas.

Country Status (10)

Country Link
EP (1) EP0487562B1 (es)
JP (1) JPH04507412A (es)
KR (1) KR920703112A (es)
AT (1) ATE119398T1 (es)
CA (1) CA2059523C (es)
DE (1) DE69017690T2 (es)
DK (1) DK0487562T3 (es)
ES (1) ES2072442T3 (es)
GB (2) GB8918879D0 (es)
WO (1) WO1991002545A1 (es)

Families Citing this family (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB9202464D0 (en) * 1992-02-05 1992-03-18 Danbiosyst Uk Composition for nasal administration
DK36492D0 (da) * 1992-03-19 1992-03-19 Novo Nordisk As Praeparat
TW404844B (en) * 1993-04-08 2000-09-11 Oxford Biosciences Ltd Needleless syringe
KR100419037B1 (ko) 1994-03-07 2004-06-12 넥타르 테라퓨틱스 폐를통한인슐린의전달방법및그조성물
US5780014A (en) * 1995-04-14 1998-07-14 Inhale Therapeutic Systems Method and apparatus for pulmonary administration of dry powder alpha 1-antitrypsin
GB0208742D0 (en) 2002-04-17 2002-05-29 Bradford Particle Design Ltd Particulate materials
US9339459B2 (en) 2003-04-24 2016-05-17 Nektar Therapeutics Particulate materials
DE10248601B4 (de) * 2002-10-17 2006-05-24 Goldstein, Naum, Dr.habil.nat. Pharmazeutisches Mittel zur endonasalen Applikation bei der Behandlung von Krankheiten und Störungen des zentralen Nervensystems
US7625865B2 (en) 2004-03-26 2009-12-01 Universita Degli Studi Di Parma Insulin highly respirable microparticles
WO2008097664A1 (en) 2007-02-11 2008-08-14 Map Pharmaceuticals, Inc. Method of therapeutic administration of dhe to enable rapid relief of migraine while minimizing side effect profile
US7791198B2 (en) 2007-02-20 2010-09-07 Nec Electronics Corporation Semiconductor device including a coupling region which includes layers of aluminum and copper alloys

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0088046B1 (de) * 1982-02-17 1987-12-09 Ciba-Geigy Ag Lipide in wässriger Phase
EP0248051A1 (en) * 1985-11-29 1987-12-09 FISONS plc Pharmaceutical composition including sodium cromoglycate
NZ222907A (en) * 1986-12-16 1990-08-28 Novo Industri As Preparation for intranasal administration containing a phospholipid absorption enhancing system
GB8712176D0 (en) * 1987-05-22 1987-06-24 Cosmas Damian Ltd Drug delivery system

Also Published As

Publication number Publication date
GB2251188B (en) 1993-04-28
DE69017690D1 (de) 1995-04-13
DE69017690T2 (de) 1995-10-19
GB2251188A (en) 1992-07-01
CA2059523A1 (en) 1991-02-19
DK0487562T3 (da) 1995-05-22
GB8918879D0 (en) 1989-09-27
JPH04507412A (ja) 1992-12-24
EP0487562B1 (en) 1995-03-08
CA2059523C (en) 1999-04-27
EP0487562A1 (en) 1992-06-03
GB9203051D0 (en) 1992-03-25
WO1991002545A1 (en) 1991-03-07
KR920703112A (ko) 1992-12-17
ATE119398T1 (de) 1995-03-15

Similar Documents

Publication Publication Date Title
NL194828B (nl) Somatostatinepeptiden, alsmede dergelijke somatostatinepeptiden bevattende farmaceutische preparaten.
ITRM920361A1 (it) Composizioni farmaceutiche contenenti un composto allilamminico quale principio attivo.
ZA917528B (en) Nasal pharmaceutical composition.
DE69001730D1 (de) Pastenfoermige, waesserige pharmazeutische zusammensetzungen.
EP0276278A4 (en) CHIMERIC PEPTIDES FOR THE DELIVERY OF NEUROPEPTIDES THROUGH THE BLOOD-BRAIN BORDER.
DE69101931D1 (de) Pharmazeutische Zusammensetzung.
PH30982A (en) Optically active 5H-pyrrolo Ä3,4-bÜ pyrazine derivative, its preparation and pharmaceutical compositions containing it.
FI963468A (fi) Menetelmät ja koostumukset insuliinin antamiseksi keuhkojen kautta
FI901102A0 (fi) Farmaceutiska kompositioner.
FI922364A0 (fi) Farmaceutiska kompositioner.
PH31205A (en) Pharmaceutical composition.
FI931031A0 (fi) Mometasonfuroatmonohydrat, foerfarande foer dess framstaellning och farmaceutiska sammansaettningar
NO933455L (no) Bis-naftalimider som inneholder aminosyreavledete linkere, for anvendelse som antikreftmidler
DE69115263D1 (de) Pharmazeutische zusammensetzungen.
DE69006094D1 (de) Pharmazeutische Zusammensetzungen.
ES2072442T3 (es) Composiciones farmaceuticas.
ES2126114T3 (es) Composiciones liquidas estables de interferon gamma.
IT1231012B (it) Composizione farmaceutica per uso orale contenente nac.
IT8820386A0 (it) Composizioni farmaceutiche orosolubili contenti acetilcisteina.
DK0577745T3 (da) Bis-naphtalimider indeholdende amid- og thioamid-forbindelsesstykker som anticancermidler.
FI923371A0 (fi) En farmaceutisk formulation.
DE69005241D1 (de) Calcitonin enthaltende pharmazeutische Zusammensetzungen.
UA32583C2 (uk) Похідні арилтіоалкілтіопіридину
FI920845A0 (fi) Farmaceutiska kompositioner innehaollande interleukin-2.
FI883008A (fi) 8 -acylaminoergolin, dess framstaellning och farmaceutiska kompositioner innehaollande detsamma.

Legal Events

Date Code Title Description
FG2A Definitive protection

Ref document number: 487562

Country of ref document: ES